Investors in Abbvie can expect a huge dividend payment. Based on the recent analysts' consensus the stock now has one of the highest dividend returns of the American market. Per share the analysts expect a dividend of 3,72 USD per share. Thus the dividend yield equals 4,78 percent. The average dividend yield of the biotech companies equals a limited 0,5 percent.
Abbvie will announce it's last quarter's results tomorrow. For this year Abbvie's revenue will be around 32,87 billion USD. This is according to the average of the analysts' estimates. This is quite more than 2017's revenue of 28,22 billion USD.
The analysts expect for 2018 a net profit of 12,28 billion USD. For this year the consensus of the result per share is a profit of 7,87 USD. The price/earnings-ratio therefore equals 9,89.
Based on the current number of outstanding shares Abbvie's market capitalization is 123,98 billion USD. The Abbvie stock was the past 12 months quite unstable. Since last November the stock is 13 percent lower. This year the stock price moved between 78 and 126 dollar.
On Wednesday the stock closed at 77,85 USD.ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com
Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.